Resources Contact Us Home Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE     Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety Image Number 13 for United States Patent #8119616. The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.       Recently Added Patents Advanced patient management with composite parameter indices Imaging apparatus and method thereof Optical system for signal amplification using a multimode fiber Motion detection system and method Data security in mobile devices Working machine Systems and methods for managing cache destage scan times   Randomly Featured Patents Balanced utility load management Semiconductor device having elongated electrostatic protection element along long side of semiconductor chip Receive squelch circuit having function of detecting pulse width Production of titania 3D display panel and method for manufacturing the same Apparatus for monitoring television receivers High strength aluminum-base alloy containing lithium and zirconium and methods of preparation Pinch valve Smoking kit for customizing a tobacco product, method for purveying a tobacco smoking product, smoking product and method of providing a smoking product Furniture base © 2006-2008 PatentGenius. All Rights Reserved.